Stem Cell Blog
Stem Cell Blog
Long COVID Stem Cell Therapy Expanded Access Program Wins FDA Approval
Key details Life-limiting condition: Long COVID’s most common symptoms, fatigue and brain fog, can have a strong negative impact on sufferers’ ability to carry out day-to-day activities, reducing quality of life and placing limits on what they are able to accomplish...
Stem Cell Patch May Aid in Spina Bifida Repair in Utero
Key details Disabling congenital defect: Spina bifida is a birth defect which causes a baby’s spine to not fully close during development, leaving part of the spinal cord exposed. Even with surgical treatment, this condition can result in disability, impacting...
Stem Cell Therapy Shows Promise for Ageing Frailty
Key details High prevalence of frailty: An estimated 12% to 24% of older adults (people aged 65 and older) suffer from ageing frailty, highlighting a significant unmet medical need. New area of research: A Phase 2b clinical trial has identified laromestrocel, an IV...
Cord Blood Banking 101: Is It Worth It for Your 2026 Baby?
The One Decision You Can’t Make After the Birth As an expectant parent, your to-do list is endless. You are researching prams, painting the nursery, and meeting potential paediatricians. But there is one item on that list that has a strict deadline: Cord Blood...
Placenta Banking vs. Encapsulation: Why Science Says Save It, Don’t Eat It
The Placenta: Superfood or Super Science? If you have spent any time on "MumTok" or pregnancy forums recently, you’ve definitely seen the debate. On one side, you have the wellness influencers swearing that turning your placenta into pills (encapsulation) is the...
Recent Posts
-
How Long Can Stem Cells Stay Frozen? New Study Finds Cells Still Working After 13 Years
-
First US Patient Treated in Phase 3 Trial of Cord Blood Stem Cell Therapy for Knee Osteoarthritis
-
Could a Blood Test at 12 Weeks Predict Pre-eclampsia?
-
Could Sibling Cord Blood Help a Child With Cerebral Palsy?
-
Cord Tissue Stem Cell Therapy for Pulmonary Fibrosis Completes First Human Safety Trial
